Found: 68
Select item for more details and to access through your institution.
Management Options for Biochemically Recurrent Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exploiting synergy: immune-based combinations in the treatment of prostate cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00351
- By:
- Publication type:
- Article
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e352, doi. 10.1016/j.clgc.2021.05.005
- By:
- Publication type:
- Article
Integrating Immunotherapies in Prostate Cancer.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 10, p. 1, doi. 10.1007/s11912-015-0469-6
- By:
- Publication type:
- Article
Nutrition in maxillofacial prosthetic patients: The unexplored frontier.
- Published in:
- Journal of Indian Prosthodontic Society, 2007, v. 7, n. 3, p. 147, doi. 10.4103/0972-4052.37679
- By:
- Publication type:
- Article
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00490
- By:
- Publication type:
- Article
The impact of leukapheresis on immune-cell number and function in patients with advanced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 11, p. 1429, doi. 10.1007/s00262-015-1738-9
- By:
- Publication type:
- Article
A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 407, doi. 10.1007/s00262-014-1524-0
- By:
- Publication type:
- Article
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 3, p. 225, doi. 10.1007/s00262-013-1505-8
- By:
- Publication type:
- Article
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 9, p. 1521, doi. 10.1007/s00262-013-1448-0
- By:
- Publication type:
- Article
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 197, doi. 10.1007/s00262-010-0927-9
- By:
- Publication type:
- Article
Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8
- By:
- Publication type:
- Article
Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4904, doi. 10.3390/cancers15194904
- By:
- Publication type:
- Article
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1361, doi. 10.3390/cancers14061361
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response.
- Published in:
- Cancers, 2012, v. 4, n. 4, p. 1229, doi. 10.3390/cancers4041229
- By:
- Publication type:
- Article
Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 2, p. 607, doi. 10.3390/tomography8020050
- By:
- Publication type:
- Article
Anthropometric analysis of palatal rugae pattern, face form and arch form among Indian population at Moradabad, India.
- Published in:
- International Dental Journal of Students' Research, 2018, v. 6, n. 1, p. 13, doi. 10.18231/2278-3784.2018.0003
- By:
- Publication type:
- Article
Lasers-changing the Face of Dentistry.
- Published in:
- Indian Journal of Public Health Research & Development, 2012, v. 3, n. 1, p. 75
- By:
- Publication type:
- Article
Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Case Report: An Uncommon Presentation of HIV-Related Lymphoma.
- Published in:
- AIDS Patient Care & STDs, 2007, v. 21, n. 7, p. 443, doi. 10.1089/apc.2006.0053
- By:
- Publication type:
- Article
Perspectives on the clinical development of immunotherapy in prostate cancer.
- Published in:
- Asian Journal of Andrology, 2018, v. 20, n. 3, p. 1, doi. 10.4103/aja.aja_9_18
- By:
- Publication type:
- Article
The path forward in prostate cancer therapeutics.
- Published in:
- Asian Journal of Andrology, 2018, v. 20, n. 3, p. 1, doi. 10.4103/aja.aja_3_18
- By:
- Publication type:
- Article
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 395, doi. 10.2967/jnumed.122.264334
- By:
- Publication type:
- Article
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264334
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A Prospective Comparison of <sup>18</sup>F-Sodium Fluoride PET/CT and PSMA-Targeted <sup>18</sup>F-DCFBC PET/CT in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 11, p. 1665, doi. 10.2967/jnumed.117.207373
- By:
- Publication type:
- Article
Prospective Study Evaluating Na<sup>18</sup>F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 886, doi. 10.2967/jnumed.115.166512
- By:
- Publication type:
- Article
The Kinetics and Reproducibility of <sup>18</sup>F-Sodium Fluoride for Oncology Using Current PET Camera Technology.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 8, p. 1175, doi. 10.2967/jnumed.111.100883
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 4, p. 475, doi. 10.1007/s00280-020-04134-9
- By:
- Publication type:
- Article
A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84960-w
- By:
- Publication type:
- Article
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2021, v. 127, n. 4, p. 435, doi. 10.1111/bju.15227
- By:
- Publication type:
- Article
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2016, v. 118, n. 4, p. 590, doi. 10.1111/bju.13412
- By:
- Publication type:
- Article
A phase I study of TRC105 anti-endoglin ( CD105) antibody in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 4, p. 546, doi. 10.1111/bju.12986
- By:
- Publication type:
- Article
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2013, v. 111, n. 8, p. 1269, doi. 10.1111/j.1464-410X.2012.11667.x
- By:
- Publication type:
- Article
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 4, p. 862, doi. 10.1002/ijc.28743
- By:
- Publication type:
- Article
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 2, p. 373, doi. 10.1002/ijc.28026
- By:
- Publication type:
- Article
Cabozantinib-Induced Thyroid Dysfunction: A Review of Two Ongoing Trials for Metastatic Bladder Cancer and Sarcoma.
- Published in:
- Thyroid, 2014, v. 24, n. 8, p. 1223, doi. 10.1089/thy.2013.0621
- By:
- Publication type:
- Article
Vaccines as Monotherapy and in Combination Therapy for Prostate Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2010, v. 3, n. 3, p. 116, doi. 10.1111/j.1752-8062.2010.00186.x
- By:
- Publication type:
- Article
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 185, doi. 10.1093/oncolo/oyad344
- By:
- Publication type:
- Article
Avelumab in Patients With Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 823, doi. 10.1093/oncolo/oyad162
- By:
- Publication type:
- Article
Relugolix in Clinical Practice: The Best Route for All?
- Published in:
- Oncologist, 2023, v. 28, n. 8, p. 647, doi. 10.1093/oncolo/oyad099
- By:
- Publication type:
- Article
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
- By:
- Publication type:
- Article
Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
- By:
- Publication type:
- Article
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single‐Dose Administration Under Fasting Conditions in Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 729, doi. 10.1002/onco.13919
- By:
- Publication type:
- Article
Disparities in Cancer Care and the Asian American Population.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 453, doi. 10.1002/onco.13748
- By:
- Publication type:
- Article
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e847, doi. 10.1002/onco.13720
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e192, doi. 10.1002/onco.13589
- By:
- Publication type:
- Article